Skip to main content
Erschienen in: Journal of Neurology 8/2014

01.08.2014 | Original Communication

Auditory neuropathy in individuals with Type 1 diabetes

verfasst von: Gary Rance, Donella Chisari, Fleur O’Hare, Leslie Roberts, Jonathan Shaw, Karin Jandeleit-Dahm, David Szmulewicz

Erschienen in: Journal of Neurology | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Peripheral neuropathy is a major consequence of diabetes mellitus with up to 50 % of patients showing clinically significant neural injury during the disease course. Hearing loss (as defined by impaired sound detection thresholds) is a recognized symptom of DM, but the possibility of auditory neuropathy (AN) has not been explored in this population. This pilot study investigated peripheral auditory function, auditory processing and speech perception in individuals with Type 1 diabetes mellitus (T1DM) and compared the findings with measures of vestibular function, ocular pathology/visual acuity and overall neurologic profile. Ten adults with T1DM and ten matched controls underwent a battery of tests which included: audiometry, otoacoustic emissions, auditory brainstem responses, temporal processing measures and speech perception. Six of the ten T1DM participants showed electrophysiologic evidence of AN and impaired functional hearing. Furthermore, auditory capacity was correlated with both visual acuity and degree of somatic peripheral neuropathy. This pilot investigation revealed functional-hearing deficits severe enough to impact upon everyday communication. Should the findings be confirmed by larger studies, auditory evaluation may form an important part of the management regimen for individuals with T1DM. This may be especially important for those with DM-related eye conditions, as deficits across multiple sensory modalities can have multiplicative detrimental effects on quality-of-life.
Literatur
1.
Zurück zum Zitat Maser RE, Steenkiste AR, Dorman JS et al (1989) Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 38:1456–1461CrossRefPubMed Maser RE, Steenkiste AR, Dorman JS et al (1989) Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 38:1456–1461CrossRefPubMed
2.
Zurück zum Zitat Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL (2012) Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol 11(6):521–534PubMedCentralCrossRefPubMed Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL (2012) Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol 11(6):521–534PubMedCentralCrossRefPubMed
3.
Zurück zum Zitat Lisowska G, Namyslowski G, Morawski K, Strojek K (2001) Early identification of hearing impairment in patients with type 1 diabetes mellitus. Otol Neurotol 22(3):316–320CrossRefPubMed Lisowska G, Namyslowski G, Morawski K, Strojek K (2001) Early identification of hearing impairment in patients with type 1 diabetes mellitus. Otol Neurotol 22(3):316–320CrossRefPubMed
4.
Zurück zum Zitat Horikawa C, Kodama S, Tanaka S et al (2013) Diabetes and risk of hearing impairment in adults: a meta-analysis. J Clin Endocrinol 98:51–58CrossRef Horikawa C, Kodama S, Tanaka S et al (2013) Diabetes and risk of hearing impairment in adults: a meta-analysis. J Clin Endocrinol 98:51–58CrossRef
5.
Zurück zum Zitat Smith TL, Raynor E, Prazima J, Buenting JE, Pillsbury HC (1995) Insulin-dependent diabetic microangiopathy in the inner ear. Laryngoscope 105(3):236–240CrossRefPubMed Smith TL, Raynor E, Prazima J, Buenting JE, Pillsbury HC (1995) Insulin-dependent diabetic microangiopathy in the inner ear. Laryngoscope 105(3):236–240CrossRefPubMed
6.
Zurück zum Zitat Jorgensen MB (1961) The inner ear in diabetes mellitus. Histological studies. Arch Otolaryngol 74:373–381CrossRefPubMed Jorgensen MB (1961) The inner ear in diabetes mellitus. Histological studies. Arch Otolaryngol 74:373–381CrossRefPubMed
7.
Zurück zum Zitat Makishima K, Tanaka K (1971) Pathological changes of the inner ear and central auditory pathway in diabetics. Ann Otol Rhinol Laryngol 80(2):218–228PubMed Makishima K, Tanaka K (1971) Pathological changes of the inner ear and central auditory pathway in diabetics. Ann Otol Rhinol Laryngol 80(2):218–228PubMed
8.
Zurück zum Zitat Starr A, Picton TW, Sininger YS, Hood LJ, Berlin CI (1996) Auditory neuropathy. Brain 119(3):741–753CrossRefPubMed Starr A, Picton TW, Sininger YS, Hood LJ, Berlin CI (1996) Auditory neuropathy. Brain 119(3):741–753CrossRefPubMed
9.
Zurück zum Zitat Rance G, Fava R, Baldock H et al (2008) Speech perception ability in individuals with Friedreich ataxia. Brain 131:2002–2012CrossRefPubMed Rance G, Fava R, Baldock H et al (2008) Speech perception ability in individuals with Friedreich ataxia. Brain 131:2002–2012CrossRefPubMed
10.
Zurück zum Zitat Rance G, Ryan MM, Bayliss K, Gill K, O’Sullivan C, Whitechurch M (2012) Auditory function in children with Charcot–Marie–Tooth disease. Brain 135:1412–1422CrossRefPubMed Rance G, Ryan MM, Bayliss K, Gill K, O’Sullivan C, Whitechurch M (2012) Auditory function in children with Charcot–Marie–Tooth disease. Brain 135:1412–1422CrossRefPubMed
11.
Zurück zum Zitat Zeng F-G, Kong Y-Y, Michaelewski HJ, Starr A (2005) Perceptual consequences of disrupted auditory nerve activity. J Neurophysiol 93:3050–3063CrossRefPubMed Zeng F-G, Kong Y-Y, Michaelewski HJ, Starr A (2005) Perceptual consequences of disrupted auditory nerve activity. J Neurophysiol 93:3050–3063CrossRefPubMed
12.
Zurück zum Zitat Rance G, O’Hare F, O’Leary S et al (2012) Auditory processing deficits in individuals with primary open angle glaucoma—evidence for neuronal susceptibility outside the visual pathways. Int J Audiol 51(1):10–15CrossRefPubMed Rance G, O’Hare F, O’Leary S et al (2012) Auditory processing deficits in individuals with primary open angle glaucoma—evidence for neuronal susceptibility outside the visual pathways. Int J Audiol 51(1):10–15CrossRefPubMed
13.
Zurück zum Zitat Fowler C, Noffsinger D (1983) Effects of stimulus repetition rate and frequency on the auditory brainstem response in normal, cochlear-impaired and VIII nerve/brainstem-impaired subjects. J Speech Hear Res 26:560–567CrossRefPubMed Fowler C, Noffsinger D (1983) Effects of stimulus repetition rate and frequency on the auditory brainstem response in normal, cochlear-impaired and VIII nerve/brainstem-impaired subjects. J Speech Hear Res 26:560–567CrossRefPubMed
14.
Zurück zum Zitat Poretti A, Palla A, Tarnutzer AA et al (2013) Vestibular impairment in patients with Charcot–Marie–Tooth disease. Neurology 80(3):2099–2105CrossRefPubMed Poretti A, Palla A, Tarnutzer AA et al (2013) Vestibular impairment in patients with Charcot–Marie–Tooth disease. Neurology 80(3):2099–2105CrossRefPubMed
15.
Zurück zum Zitat Chia EM, Mitchell P, Rochtchina E et al (2006) Association between vision and hearing impairments and their combined effects on quality of life. Arch Opthalmol 124(10):1465–1470CrossRef Chia EM, Mitchell P, Rochtchina E et al (2006) Association between vision and hearing impairments and their combined effects on quality of life. Arch Opthalmol 124(10):1465–1470CrossRef
Metadaten
Titel
Auditory neuropathy in individuals with Type 1 diabetes
verfasst von
Gary Rance
Donella Chisari
Fleur O’Hare
Leslie Roberts
Jonathan Shaw
Karin Jandeleit-Dahm
David Szmulewicz
Publikationsdatum
01.08.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 8/2014
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-014-7371-2

Weitere Artikel der Ausgabe 8/2014

Journal of Neurology 8/2014 Zur Ausgabe

Pioneers in Neurology

Robert Bartholow (1831–1904)

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.